The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
MicroRNAs in the p53 network: micromanagement of tumour suppression
Abstract
In recent years, microRNAs (miRNAs) have been identified as mediators of tumour suppression and stress responses exerted by the p53 tumour suppressor. p53-regulated miRNAs contribute to tumour suppression by controlling the expression of central components of multiple processes, including cell cycle progression, epithelial-mesenchymal transition, stemness, metabolism, cell survival and angiogenesis. The expression and activity of p53 itself is also under the control of miRNAs. Finally, genetic and epigenetic alterations identified in the p53-miRNA network indicate that these pathways are important for the initiation and progression of tumours. In the future, knowledge about the p53-miRNA network may be able to be exploited for diagnostic and therapeutic approaches in cancer prevention and treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several noncoding RNAs were reported to mediate p53-dependent gene regulation—these include microRNAs120 and long noncoding RNAs,121 such as TUG1,122, 123 miR-34,124 lincRNA-p21,125 PANDA126 and PINT.127”
From Census and evaluation of p53 target genes (2017) · cites this paper as [120]
Citations
Cites
2 retracted
Pichiorri, F., Suh, S.-S., Rocci, A., De Luca, L., Taccioli, C., Santhanam, R., Zhou, W., Benson, D. M., Hofmainster, C., Alder, H., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.005 · Cited by 436
RetractedA TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
Melo, S. A., Ropero, S., Moutinho, C., Aaltonen, L. A., Yamamoto, H., Calin, G. A., Rossi, S., Fernández, A. F., Carneiro, F., Oliveíra, C., et al. (2009) · Nature Genetics · doi:10.1038/ng.317 · Cited by 375
RetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew‐Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,852
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,579
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Regulation of mRNA Translation and Stability by microRNAs
Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060308-103103 · Cited by 3,214
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Calin, G. A., Ferracin, M., Cimmino, A., Leva, G. D., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. İ., Fabbri, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050995 · Cited by 2,415
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
The epigenetic progenitor origin of human cancer
Feinberg, A. P., OHLSSON, R. I., & Henikoff, S. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,885
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Wellner, U. F., Schubert, J., Burk, U., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D. S., Hausen, A. Z., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1998 · Cited by 1,733
Burk, U., Schubert, J., Wellner, U. F., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO Reports · doi:10.1038/embor.2008.74 · Cited by 1,722
MicroRNAs in Stress Signaling and Human Disease
Mendell, J. T., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.02.005 · Cited by 1,673
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,642
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Mayr, C., & Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.06.016 · Cited by 1,613
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Roles for MicroRNAs in Conferring Robustness to Biological Processes
Ebert, M. S., & Sharp, P. A. (2012) · Cell · doi:10.1016/j.cell.2012.04.005 · Cited by 1,564
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun‐Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C. R., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,410
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N. B.-C., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,365
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,362
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236
Self-citationDownregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Shimono, Y., Zabala, M., Cho, R. W., Lobo, N. A., Dalerba, P. D., Qian, D., Diehn, M., Liu, H., Panula, S., Chiao, E. T., et al. (2009) · Journal of End-to-End-testing · doi:10.1016/j.cell.2009.07.011 · Cited by 1,220
MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Xu, N., Papagiannakopoulos, T. Y., Pan, G., Thomson, J. A., & Kosik, K. S. (2009) · Cell · doi:10.1016/j.cell.2009.02.038 · Cited by 1,160
Modulation of microRNA processing by p53
Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., & Miyazono, K. (2009) · Nature · doi:10.1038/nature08199 · Cited by 1,158
MicroRNAs in metabolism and metabolic disorders
Rottiers, V., & Näär, A. M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3313 · Cited by 1,156
p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R. D., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.068 · Cited by 1,135
Disrupting the Pairing Between let-7 and Hmga2 Enhances Oncogenic Transformation
Mayr, C., Hemann, M. T., & Bartel, D. P. (2007) · Science · doi:10.1126/science.1137999 · Cited by 1,112
A microRNA DNA methylation signature for human cancer metastasis
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez‐Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,093
Lujambio, A., & Lowe, S. W. (2012) · Nature · doi:10.1038/nature10888 · Cited by 1,084
Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs
Tay, Y., Kats, L. M., Salmena, L., Weiss, D., Tan, S. M., Ala, U., Karreth, F. A., Poliseno, L., Provero, P., Cunto, F. D., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.029 · Cited by 1,025
The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Bonci, D., Coppola, V., Musumeci, M., Addario, A., Giuffrida, R., Memeo, L., D’Urso, L., Pagliuca, A., Biffoni, M., Labbaye, C., et al. (2008) · Nature Medicine · doi:10.1038/nm.1880 · Cited by 998
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Kasinski, A. L., & Slack, F. J. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3166 · Cited by 956
Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., & Hermeking, H. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4436 · Cited by 935
Self-citationThe Lin28/let-7 Axis Regulates Glucose Metabolism
Zhu, H., Shyh‐Chang, N., Segrè, A. V., Shinoda, G., Shah, S. P., Einhorn, W. S., Takeuchi, A., Engreitz, J., Hagan, J. P., Kharas, M. G., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.033 · Cited by 916
Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R., & Gu, W. (2012) · Cell · doi:10.1016/j.cell.2012.04.026 · Cited by 912
Snail blocks the cell cycle and confers resistance to cell deathPreprint
Vega, S., Morales, A. V., Ocaña, O. H., Valdés, F., Fabregat, I., & Nieto, M. A. (2004) · Genes & Development · doi:10.1101/gad.294104 · Cited by 866
MicroRNA functions in stress responses
Leung, A. K. L., & Sharp, P. A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.027 · Cited by 865
Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
DeBerardinis, R. J., & Thompson, C. B. (2012) · Cell · doi:10.1016/j.cell.2012.02.032 · Cited by 858
Klein, U., Lia, M., Crespo, M., Siegel, R., Shen, Q. “., Mo, T., Ambesi‐Impiombato, A., Califano, A., Migliazza, A., Bhagat, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.019 · Cited by 851
p53 represses c-Myc through induction of the tumor suppressor miR-145
Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S. R., Elble, R. C., Watabe, K., & Mo, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808042106 · Cited by 841
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
Welch, C., Chen, Y., & Stallings, R. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210293 · Cited by 805
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Koerner, H., Knyazev, P. G., Diebold, J., & Hermeking, H. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6533 · Cited by 795
Self-citationp53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
Chang, C.-J., Chao, C.-H., Xia, W., Yang, J.-Y., Xiong, Y., Li, C., Yu, W.-H., Rehman, S. K., Hsu, J. L., Lee, H., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2173 · Cited by 771
DICER1 Mutations in Familial Pleuropulmonary Blastoma
Hill, D. A., Ivanovich, J., Priest, J. R., Gurnett, C. A., Dehner, L. P., Desruisseau, D., Jarzembowski, J. A., Wikenheiser-Brokamp, K. A., Suarez, B. K., Whelan, A. J., et al. (2009) · Science · doi:10.1126/science.1174334 · Cited by 751
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue
Wong, T., Liu, X., Wong, B. Y., Ng, R. W. M., Yuen, A. P. W., & Wei, W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0666 · Cited by 751
Mediation of c-Myc-Induced Apoptosis by p53
Hermeking, H., & Eick, D. (1994) · Science · doi:10.1126/science.8091232 · Cited by 741
Self-citationp53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
Vaseva, A. V., Marchenko, N. D., Ji, K., Tsirka, S. E., Holzmann, S., & Moll, U. M. (2012) · Cell · doi:10.1016/j.cell.2012.05.014 · Cited by 740
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
Merritt, W. M., Lin, Y. G., Han, L. Y., Kamat, A. A., Spannuth, W. A., Schmandt, R. E., Urbauer, D. L., Pennacchio, L. A., Cheng, J., Nick, A. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803785 · Cited by 731
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J. T., Bommer, G. T., Fan, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006816 · Cited by 699
Trang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., & Slack, F. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.48 · Cited by 682
A MicroRNA Targeting Dicer for Metastasis Control
Martello, G., Rosato, A., Ferrari, F., Manfrin, A., Cordenonsi, M., Dupont, S., Enzo, E., Guzzardo, V., Rondina, M. B., Spruce, T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.017 · Cited by 680
MicroRNA-125b is a novel negative regulator of p53Preprint
Le, M. T. N., Teh, C., Shyh‐Chang, N., Xie, H., Zhou, B., Korzh, V. P., Lodish, H. F., & Lim, B. (2009) · Genes & Development · doi:10.1101/gad.1767609 · Cited by 669
Corney, D. C., Flesken‐Nikitin, A., Godwin, A. K., Wang, W., & Nikitin, A. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1585 · Cited by 659
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
Siemens, H., Jackstadt, R., Hünten, S., Kaller, M., Menssen, A., Götz, U., & Hermeking, H. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18552 · Cited by 627
Self-citationThe interplay between MYC and HIF in cancer
Dang, C. V., Kim, J., Gao, P., & Yustein, J. T. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2274 · Cited by 621
miR-29 miRNAs activate p53 by targeting p85α and CDC42
Park, S. Y., Lee, J. H., Ha, M., Nam, J., & Kim, V. N. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1533 · Cited by 615
Toyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y., & Tokino, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0325 · Cited by 615
Reduced expression of Dicer associated with poor prognosis in lung cancer patients
Karube, Y., Tanaka, H., Osada, H., Tomida, S., Tatematsu, Y., Yanagisawa, K., Yatabe, Y., Takamizawa, J., Miyoshi, S., Mitsudomi, T., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00015.x · Cited by 613
The expanding universe of p53 targets
Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568
Hur, K., Toiyama, Y., Takahashi, M., Balaguer, F., Nagasaka, T., Koike, J., Hemmi, H., Koi, M., Boland, C. R., & Goel, A. (2012) · Gut · doi:10.1136/gutjnl-2011-301846 · Cited by 537
p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
Kim, T., Veronese, A., Pichiorri, F., Lee, T. J., Jeon, Y.-J., Volinia, S., Pineau, P., Marchio, A., Palatini, J., Suh, S.-S., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110235 · Cited by 531
Hermeking, H. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.028 · Cited by 505
Self-citationp53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest
Braun, C. J., Zhang, X., Savelyeva, I., Wolff, S., Moll, U. M., Schepeler, T., Orntoft, T. F., Andersen, C. L., & Dobbelstein, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1569 · Cited by 476
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition
Kim, N. H., Kim, H. S., Li, X.-Y., Lee, I., Choi, H.-S., Kang, S. E., Cha, S. Y., Ryu, J. K., Yoon, D., Fearon, E. R., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201103097 · Cited by 445
Dicer1 functions as a haploinsufficient tumor suppressorPreprint
Kumar, M. S., Pester, R. E., Chen, C. Y., Lane, K. M., Chin, C., Lü, J., Kirsch, D. G., Golub, T. R., & Jacks, T. (2009) · Genes & Development · doi:10.1101/gad.1848209 · Cited by 437
Hermeking, H. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1230 · Cited by 436
Self-citationP53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
Yamakuchi, M., Lotterman, C., Bao, C., Hruban, R. H., Karim, B. O., Mendell, J. T., Huso, D. L., & Lowenstein, C. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911082107 · Cited by 433
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Su, X., Chakravarti, D., Cho, M. S., Liu, L.-Z., Gi, Y. J., Lin, Y.-L., Leung, M. L., El‐Naggar, A. K., Creighton, C. J., Suraokar, M. B., et al. (2010) · Nature · doi:10.1038/nature09459 · Cited by 429
Fornari, F., Gramantieri, L., Giovannini, C., Veronese, A., Ferracin, M., Sabbioni, S., Calin, G. A., Grazi, G. L., Croce, C. M., Tavolari, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4797 · Cited by 400
miR-34 miRNAs provide a barrier for somatic cell reprogramming
Choi, Y. J., Lin, C., Ho, J. J., He, X., Okada, N., Bu, P., Zhong, Y., Kim, S. Y., Bennett, M. J., Chen, C., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2366 · Cited by 387
Bandi, N., Zbinden, S., Gugger, M., Arnold, M., Kocher, V., Hasan, L., Каппелер, А., Brunner, T., & Vassella, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4277 · Cited by 386
The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cells
Brabletz, S., Bajdak-Rusinek, K., Meidhof, S., Burk, U., Niedermann, G., Firat, E., Wellner, U. F., Dimmler, A. W., Faller, G., Schubert, J., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.349 · Cited by 369
Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer
Wiklund, E. D., Bramsen, J. B., Hulf, T., Dyrskjøt, L., Ramanathan, R., Hansen, T. B., Villadsen, S. B., Gao, S., Ostenfeld, M. S., Borre, M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25461 · Cited by 367
miR‐15a and miR‐16‐1 down‐regulation in pituitary adenomas
Bottoni, A., Piccin, D., Tagliati, F., Luchin, A., Zatelli, M. C., & Uberti, E. C. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20282 · Cited by 360
Dávalos, V., Moutinho, C., Villanueva, A., Boqué-Sastre, R., Silva, P., Carneiro, F., & Esteller, M. (2011) · Oncogene · doi:10.1038/onc.2011.383 · Cited by 358
Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
Georges, S. A., Biery, M. C., Kim, S., Schelter, J. M., Guo, J., Chang, A. N., Jackson, A. L., Carleton, M. O., Linsley, P. S., Cleary, M. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1846 · Cited by 348
A Genetic Defect in Exportin-5 Traps Precursor MicroRNAs in the Nucleus of Cancer Cells
Melo, S. A., Moutinho, C., Ropero, S., Calin, G. A., Rossi, S., Spizzo, R., Fernández, A. F., Dávalos, V., Villanueva, A., Montoya, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.007 · Cited by 347
Dave, N., Guaita‐Esteruelas, S., Gutarra, S., Frías, A., Beltran-Nebot, M., Peiró, S., & de Herreros, A. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.168625 · Cited by 346
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Gallardo, E., Navarro, A., Viñolas, N., Marrades, R. M., Díaz, T., Gel, B., Quera, A., Bandrés, E., García‐Foncillas, J., Ramirez, J., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp219 · Cited by 346
DICER1 Mutations in Familial Multinodular Goiter With and Without Ovarian Sertoli-Leydig Cell Tumors
Frio, T. R. (2011) · JAMA · doi:10.1001/jama.2010.1910 · Cited by 341
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Hu, W., Chan, C. S., Wu, R., Zhang, C., Sun, Y., Song, J. S., Tang, L. H., Levine, A. J., & Feng, Z. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.027 · Cited by 321
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
Corney, D. C., Hwang, C., Matoso, A., Vogt, M., Flesken‐Nikitin, A., Godwin, A. K., Kamat, A. A., Sood, A. K., Ellenson, L. H., Hermeking, H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2642 · Cited by 314
Self-citationVogt, M., Munding, J. B., Grüner, M., Liffers, S., Verdoodt, B., Hauk, J., Steinstraesser, L., Tannapfel, A., & Hermeking, H. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-1030-5 · Cited by 312
Self-citationp53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
Kim, N. H., Kim, N.-G., Kim, N.-G., Lee, I., Choi, H.-S., Li, X.-Y., Kang, S. E., Cha, S. Y., Ryu, J. K., Na, J. M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001744 · Cited by 311
Repression of the miR‐17‐92 cluster by p53 has an important function in hypoxia‐induced apoptosis
Yan, H., Xue, G., Mei, Q., Wang, Y.-Z., Ding, F., Liu, M., Lü, M., Tang, Y., Yu, H., & Sun, S. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.214 · Cited by 304
Ceppi, P., Mudduluru, G., Kumarswamy, R., Rapa, I., Scagliotti, G. V., Papotti, M. G., & Allgayer, H. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0052 · Cited by 304
Fabbri, M., Bottoni, A., Shimizu, M., Spizzo, R., Nicoloso, M. S., Rossi, S., Barbarotto, E., Cimmino, A., Adair, B., Wojcik, S. E., et al. (2011) · JAMA · doi:10.1001/jama.2010.1919 · Cited by 294
Negative regulation of the tumor suppressor p53 gene by microRNAs
Kumar, M., Lu, Z., Takwi, A. A., Chen, W., Callander, N. S., Ramos, K. S., Young, K. H., & Li, Y. (2010) · Oncogene · doi:10.1038/onc.2010.457 · Cited by 287
Vrba, L., Jensen, T. J., Garbe, J. C., Heimark, R. L., Cress, A. E., Dickinson, S., Stampfer, M. R., & Futscher, B. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008697 · Cited by 285
Tellez, C. S., Juri, D. E., Do, K., Bernauer, A. M., Thomas, C. L., Damiani, L. A., Tessema, M., Leng, S., & Belinsky, S. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3035 · Cited by 282
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
Hu, X., MacDonald, D. M., Huettner, P. C., Feng, Z., Naqa, I. E., Schwarz, J. K., Mutch, D. G., Grigsby, P. W., Powell, S. N., & Wang, X. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.022 · Cited by 280
Menssen, A., Hydbring, P., Kapelle, K., Vervoorts, J., Diebold, J., Lüscher, B., Larsson, L., & Hermeking, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105304109 · Cited by 275
Self-citationThe promises and perils of p53
Krizhanovsky, V., & Lowe, S. W. (2009) · Nature · doi:10.1038/4601085a · Cited by 274
Zhang, Y., Yan, L., Wu, Q.-N., Du, Z.-M., Chen, J., Liao, D.-Z., Huang, M., Hou, J.-H., Wu, Q., Zeng, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2435 · Cited by 272
Eades, G. L., Yao, Y., Yang, M., Zhang, Y., Chumsri, S., & Zhou, Q. Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229401 · Cited by 263
Aging and chronic DNA damage response activate a regulatory pathway involving miR‐29 and p53
Ugalde, A. P., Ramsay, A. J., Rosa, J. D. L., Varela, I., Mariño, G., Cadiñanos, J., Lü, J., Freije, J. M. P., & López-Otı́n, C. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.124 · Cited by 260
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
Mudduluru, G., Ceppi, P., Kumarswamy, R., Scagliotti, G. V., Papotti, M., & Allgayer, H. (2011) · Oncogene · doi:10.1038/onc.2011.13 · Cited by 257
Lal, A., Thomas, M. P., Altschuler, G. M., Navarro, F., O’Day, E. M., Li, X. L., Concepcion, C. P., Han, Y.-C., Thiery, J., Rajani, D. K., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002363 · Cited by 249
Bousquet, M., Quelen, C., Rosati, R., Mas, V. M., Starza, R. L., Bastard, C., Lippert, É., Talmant, P., Lafage‐Pochitaloff, M., Leroux, D., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080285 · Cited by 248
Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies
Wong, K. Y., So, C. C., Loong, F., Chung, L.-P., Lam, W. W. L., Liang, R. H. S., Li, G. K. H., Jin, D., & Chim, C. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019027 · Cited by 247
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
Kheir, T. B., Futoma-Kazmierczak, E., Skanderup, A. J., Krogh, A., Bardram, L., Hother, C. E., Grønbæk, K., Federspiel, B., Lund, A. H., & Friis-Hansen, L. J. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-29 · Cited by 247
MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
Bhattacharya, R., Nicoloso, M. S., Arvizo, R. R., Wang, E., Cortez, A., Rossi, S., Calin, G. A., & Mukherjee, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2552 · Cited by 242
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer
Musumeci, M., Coppola, V., Addario, A., Patrizii, M., Maugeri‐Saccà, M., Memeo, L., Colarossi, C., Francescangeli, F., Biffoni, M., Collura, D., et al. (2011) · Oncogene · doi:10.1038/onc.2011.140 · Cited by 240
Tivnan, A., Orr, W. S., Gubala, V., Nooney, R. I., Williams, D. E., McDonagh, C. M., Prenter, S., Harvey, H. M., Domingo-Fernandéz, R., Bray, I. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038129 · Cited by 239
p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells
Jain, A. K., Allton, K. L., Iacovino, M., Mahen, E. M., Milczarek, R. J., Zwaka, T. P., Kyba, M., & Barton, M. C. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001268 · Cited by 237
Spizzo, R., Nicoloso, M. S., Croce, C. M., & Calin, G. A. (2009) · Cell · doi:10.1016/j.cell.2009.04.040 · Cited by 232
Lee, K.-H., Lotterman, C., Karikari, C. A., Omura, N., Feldmann, G., Habbe, N., Goggins, M., Mendell, J. T., & Maitra, A. (2009) · Pancreatology · doi:10.1159/000186051 · Cited by 223
Kaller, M., Liffers, S., Oeljeklaus, S., Kuhlmann, K., Röh, S., Hoffmann, R. F. G., Warscheid, B., & Hermeking, H. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010462 · Cited by 209
Self-citationMicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer
Suh, S. O., Chen, Y., Zaman, M. S., Hirata, H., Yamamura, S., Shahryari, V., Liu, J., Tabatabai, Z. L., Kakar, S., Deng, G., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr036 · Cited by 207
Swarbrick, A., Woods, S. L., Shaw, A., Balakrishnan, A., Phua, Y. W., Nguyen, A., Chanthery, Y. H., Lim, L., Ashton, L. J., Judson, R. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2227 · Cited by 202
Leucci, E., Cocco, M., Onnis, A., Falco, G. D., van Cleef, P., Bellan, C., van Rijk, A. F., Nyagol, J. A., Byakika, B., Lazzi, S., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2410 · Cited by 201
Suzuki, H., Yamamoto, E., Nojima, M., Kai, M., Yamano, H., Yoshikawa, K., Kimura, T., Kudo, T., Harada, E., Sugai, T., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq203 · Cited by 197
microRNAs: A Safeguard against Turmoil?
Leung, A. K. L., & Sharp, P. A. (2007) · Cell · doi:10.1016/j.cell.2007.08.010 · Cited by 196
Dysregulation of miR-15a and miR-214 in human pancreatic cancer
Zhang, X., Ye, H., Zeng, C., He, B., Zhang, H., & Chen, Y. Q. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-46 · Cited by 195
CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation
Burns, D. M., D’Ambrogio, A., Nottrott, S., & Richter, J. D. (2011) · Nature · doi:10.1038/nature09908 · Cited by 193
miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress
Xiao, J., Lin, H., Luo, X., Luo, X., & Wang, Z. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.347 · Cited by 189
Down-regulation of miR-141 in gastric cancer and its involvement in cell growth
Du, Y., Xu, Y., Ding, L., Yao, H., Yu, H., Zhou, T., & Si, J. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0037-7 · Cited by 183
Earle, J. S. L., Luthra, R., Romans, A., Abraham, R., Ensor, J., Yao, H., & Hamilton, S. R. (2010) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2010.090154 · Cited by 182
MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors
Amaral, F. C., Torres, N., Saggioro, F. P., Neder, L., Machado, H. R., Silva, W. A., Moreira, A. C., & de Castro, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1451 · Cited by 182
Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells
Mudhasani, R., Zhu, Z., Hutvágner, G., Eischen, C. M., Lyle, S. R., Hall, L. L., Lawrence, J. B., Imbalzano, A. N., & Jones, S. N. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200802105 · Cited by 180
Diederichs, S., & Haber, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0537 · Cited by 178
Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells
Neves, R. P., Scheel, C., Weinhold, S., Honisch, E., Iwaniuk, K. M., Trompeter, H., Niederacher, D., Wernet, P., Santourlidis, S., & Uhrberg, M. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-219 · Cited by 177
miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1
Roybal, J. D., Zang, Y., Ahn, Y., Yang, Y., Gibbons, D. L., Baird, B. N., Alvarez, C., Thilaganathan, N., Liu, D. D., Saintigny, P., et al. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0497 · Cited by 174
In-depth characterization of the microRNA transcriptome in a leukemia progression modelPreprint
Kuchenbauer, F. C., Morin, R. D., Argiropoulos, B., Petriv, O. I., Griffith, M., Heuser, M., Yung, E., Piper, J., Delaney, A. D., Prabhu, A., et al. (2008) · Genome Research · doi:10.1101/gr.077578.108 · Cited by 173
mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1
Schickel, R., Park, S.-M., Murmann, A. E., & Peter, M. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.018 · Cited by 167
Pallasch, C. P., Patz, M., Park, Y. J., Hagist, S., Eggle, D., Claus, R., Debey‐Pascher, S., Schulz, A., Frenzel, L. P., Claasen, J., et al. (2009) · Blood · doi:10.1182/blood-2009-06-229898 · Cited by 164
A pipeline for the generation of shRNA transgenic mice
Dow, L. E., Premsrirut, P. K., Zuber, J., Fellmann, C., McJunkin, K., Miething, C., Park, Y., Dickins, R. A., Hannon, G. J., & Lowe, S. W. (2012) · Nature Protocols · doi:10.1038/nprot.2011.446 · Cited by 159
Ragimov, N., Krauskopf, A., Navot, N., Rotter, V., Oren, M., & Aloni, Y. (1993) · PubMed · Cited by 159
Le, M. T. N., Shyh-Chang, N., Khaw, S. L., Chin, L., Teh, C., Tay, J., O'Day, E., Korzh, V., Yang, H., Lal, A., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002242 · Cited by 158
Vallejo, D. M., Caparrós, E., & Domínguez, M. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.358 · Cited by 157
Bandi, N., & Vassella, E. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-55 · Cited by 157
Epigenetic inactivation of the miR-34a in hematological malignancies
Chim, C. S., Wong, K. Y., Qi, Y., Loong, F., Lam, W. L., Wong, L., Jin, D., Costello, J., & Liang, R. H. S. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq033 · Cited by 157
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
Gan, B., Lim, C., Chu, G., Hua, S., Ding, Z., Collins, M. P., HU, J. L., Jiang, S., Fletcher-Sananikone, E., Zhuang, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.019 · Cited by 149
Bui, T. V., & Mendell, J. T. (2010) · Genes & Cancer · doi:10.1177/1947601910377491 · Cited by 143
MicroRNA miR-125b is a prognostic marker in human colorectal cancer
Mori (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.969 · Cited by 139
MicroRNA-449 in cell fate determination
Lizé, M., Klimke, A., & Dobbelstein, M. (2011) · Cell Cycle · doi:10.4161/cc.10.17.17181 · Cited by 138
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression
Hwang, C., Matoso, A., Corney, D. C., Flesken‐Nikitin, A., Körner, S., Wang, W., Boccaccio, C., Thorgeirsson, S. S., Comoglio, P. M., Hermeking, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017536108 · Cited by 137
Self-citationPrognostic Significance of miR-215 in Colon Cancer
Karaayvaz, M., Pal, T., Song, B., Zhang, C., Georgakopoulos, P., Mehmood, S., Burke, S., Shroyer, K., & Ju, J. (2011) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2011.06.002 · Cited by 130
Kubo, T., Toyooka, S., Tsukuda, K., Sakaguchi, M., Fukazawa, T., Soh, J., Asano, H., Ueno, T., Muraoka, T., Yamamoto, H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3040 · Cited by 125
DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer
Wang, Z., Chen, Z., Gao, Y., Li, N., Li, B., Tan, F., Tan, X., Lü, N., Sun, Y., Sun, J., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.5.14550 · Cited by 125
miRNA regulation of Sdf1 chemokine signaling provides genetic robustness to germ cell migration
Staton, A. A., Knaut, H., & Giráldez, A. J. (2011) · Nature Genetics · doi:10.1038/ng.758 · Cited by 121
Zhu, H., Dougherty, U., Robinson, V. L., Mustafi, R., Pekow, J. R., Kupfer, S. S., Li, Y.-C., Hart, J. A. L., Goss, K. H., Fichera, A., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0531 · Cited by 118
CpG island methylation status of miRNAs in esophageal squamous cell carcinoma
Chen, X., Hu, H., Guan, X., Xiong, G., Wang, Y., Wang, K., Li, J., Xu, X., Yang, K., & Bai, Y. (2011) · International Journal of Cancer · doi:10.1002/ijc.26171 · Cited by 115
Kim, M. S., Oh, J. E., Kim, Y. R., Park, S. W., Kang, M. R., Kim, S. S., An, C. H., Yoo, N. J., & Lee, S. H. (2010) · The Journal of Pathology · doi:10.1002/path.2683 · Cited by 114
miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal
Herrera-Merchan, A., Cerrato, C., Luengo, G., Domı́nguez, O., Piris, M. A., Serrano, M., & González, S. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12598 · Cited by 113
Li, X., Zhang, Y., Shi, Y., Dong, G., Liang, J., Han, Y., Wang, X., Zhao, Q., Ding, J., Wu, K., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01194.x · Cited by 112
Li, W., Chen, C., Xu, M., Guo, J., Li, Y., Xia, Q., Liu, H., He, J., Yu, H., & Zhu, L. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08075.x · Cited by 110
Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity
Léveillé, N., Elkon, R., Dávalos, V., Manoharan, V., Hollingworth, D., Vrielink, J. A. F. O., le Sage, C., Melo, C. A., Horlings, H. M., Wesseling, J., et al. (2011) · Nature Communications · doi:10.1038/ncomms1519 · Cited by 101
A resource of vectors and ES cells for targeted deletion of microRNAs in mice
Prosser, H. M., Koike-Yusa, H., Cooper, J. D., Law, F., & Bradley, A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1929 · Cited by 92
Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer
Kalimutho, M., Cecilia, S. D., Blanco, G. D. V., Roviello, F., Sileri, P., Cretella, M., Formosa, A., Corso, G., Marrelli, D., Pallone, F., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.82 · Cited by 90
Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34a
Chen, Q., Yu, L., Tsang, P., Wei, J. S., Song, Y., Cheuk, A., Chung, J., Hewitt, S. M., Veenstra, T. D., & Khan, J. I. (2010) · Journal of Proteome Research · doi:10.1021/pr1006697 · Cited by 89
Panda, H., Pelakh, L., Chuang, T., Luo, X., Bükülmez, O., & Chegini, N. (2012) · Reproductive Sciences · doi:10.1177/1933719112438448 · Cited by 87
MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3′ untranslated region
Tian, S., Huang, S., Wu, S., Guo, W., Li, J., & He, X. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.112 · Cited by 86
Böhlig, L., Friedrich, M., & Engeland, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq796 · Cited by 85
Eμ/miR-125b transgenic mice develop lethal B-cell malignancies
Enomoto, Y., Kitaura, J., Hatakeyama, K., Watanuki, J., Akasaka, T., Kato, N., Shimanuki, M., Nishimura, K., Takahashi, M., Taniwaki, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.166 · Cited by 81
Kahlert, C., Klupp, F., Brand, K., Lasitschka, F., Diederichs, S., Kirchberg, J., Rahbari, N. N., Dutta, S., Bork, U., Fritzmann, J., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02023.x · Cited by 81
A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes
Careccia, S., Mainardi, S., Pelosi, A., Gurtner, A., Diverio, D., Riccioni, R., Testa, U., Pelosi, E., Piaggio, G., Sacchi, A., et al. (2009) · Oncogene · doi:10.1038/onc.2009.255 · Cited by 81
TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
Soussi, T. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-386469-7.00005-0 · Cited by 77
p53 connects tumorigenesis and reprogramming to pluripotency
Tàpia, N., & Schöler, H. R. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101866 · Cited by 71
Li, N., Kaur, S., Greshock, J., Lassus, H., Zhong, X.-M., Wang, Y., Leminen, A., Shao, Z.-M., Hu, X., Liang, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2484 · Cited by 67
Proliferation and Tumorigenesis of a Murine Sarcoma Cell Line in the Absence of DICER1
Ravi, A., Gurtan, A. M., Kumar, M. S., Bhutkar, A. J., Chin, C., Lu, V., Lees, J. A., Jacks, T., & Sharp, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.037 · Cited by 66
Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met
Cai (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000378 · Cited by 63
MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
Dong, F., & Lou, D. (2012) · PubMed Central · Cited by 62
To repress or not to repress: This is the guardian's question
Rinn, J. L., & Huarte, M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.04.002 · Cited by 60
Leaderer, D., Hoffman, A. E., Zheng, T., Fu, A., Weidhaas, J. B., Paranjape, T., & Zhu, Y. (2011) · Europe PMC (PubMed Central) · Cited by 60
Rücker, F. G., Russ, A. C., Cocciardi, S., Kett, H., Schlenk, R. F., Botzenhardt, U., Langer, C., Krauter, J., Fröhling, S., Schlegelberger, B., et al. (2012) · Leukemia · doi:10.1038/leu.2012.208 · Cited by 49
The miR‐15a‐miR‐16‐1 locus is homozygously deleted in a subset of prostate cancers
Porkka, K. P., Ogg, E.-L., Saramäki, O. R., Vessella, R. L., Pukkila, H., Lähdesmäki, H. J., van Weerden, W. M., Wolf, M., Kallioniemi, O., Jenster, G. W., et al. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20873 · Cited by 47
BM-ca is a newly defined type I/II anti-CD20 monoclonal antibody with unique biological properties
Nishida (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.864 · Cited by 45
Brabletz, T. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18900 · Cited by 44
Epigenetic Alteration of DNA in Mucosal Wash Fluid Predicts Invasiveness of Colorectal Tumors
Kamimae, S., Yamamoto, E., Yamano, H., Nojima, M., Suzuki, H., Ashida, M., Hatahira, T., Satô, A., Kimura, T., Yoshikawa, K., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0214 · Cited by 41
Chang, C.-J., Chao, C.-H., Xia, W., Yang, J.-Y., Xiong, Y., Li, C.-W., Yu, W.-H., Rehman, S. K., Hsu, J. L., Lee, H., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2401 · Cited by 15
Flagged first, then by citations
Cited by
Sorted by citations
Jansson, M., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,150
P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
MicroRNA-34a regulates cardiac ageing and function.
Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., et al. (2013) · Nature · doi:10.1038/nature11919 · Cited by 821
Self-citationTumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
Borrero, L. J. H., & El‐Deiry, W. S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188556 · Cited by 805
Metadata
- Authors
- Hermeking, H.
- Affiliations
- Pathologisches Institut (DE)
- Corresponding author
- Hermeking, Heiko
- ORCID
- Hermeking, Heiko
- Venue
- Nature Reviews Cancer
- Published
- 2012-08-17
- Volume
- 12
- Issue
- 9
- Pages
- 613-626
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1970431885
- Cited by
- 518
- References
- 185
- Citations by year
- 2026: 13 · 2025: 8 · 2024: 29 · 2023: 23 · 2022: 34 · 2021: 29 · 2020: 32 · 2019: 31 · 2018: 31 · 2017: 44 · 2016: 54 · 2015: 59 · 2014: 76 · 2013: 47 · 2012: 8
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- microRNA, p53, tumor suppression, p53 pathway, cell cycle regulation, epithelial-mesenchymal transition, cancer stemness, cancer metabolism, angiogenesis, cell survival, epigenetic modifications, cancer diagnosis, cancer therapeutics
- MeSH terms
- Humans, Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review